These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37846772)

  • 1. Patterns of antiseizure medication utilization in the Human Epilepsy Project.
    Fox J; Barnard S; Agashe SH; Holmes MG; Gidal B; Klein P; Abou-Khalil BW; French J;
    Epilepsia; 2023 Dec; 64(12):3196-3204. PubMed ID: 37846772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Adverse Effects of Commonly Prescribed Antiseizure Medications in Adults With Newly Diagnosed Focal Epilepsy.
    Barnard SN; Chen Z; Kanner AM; Holmes MG; Klein P; Abou-Khalil BW; Gidal BE; French J; Perucca P;
    Neurology; 2024 Oct; 103(7):e209821. PubMed ID: 39270150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in antiseizure medication prescription patterns among all adults, women, and older adults with epilepsy: A German longitudinal analysis from 2008 to 2020.
    Hochbaum M; Kienitz R; Rosenow F; Schulz J; Habermehl L; Langenbruch L; Kovac S; Knake S; von Podewils F; von Brauchitsch S; Hamacher M; Strzelczyk A; Willems LM
    Epilepsy Behav; 2022 May; 130():108666. PubMed ID: 35339390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations.
    Cohen JM; Alvestad S; Cesta CE; Bjørk MH; Leinonen MK; Nørgaard M; Einarsdóttir K; Engeland A; Gissler M; Karlstad Ø; Klungsøyr K; Odsbu I; Reutfors J; Selmer RM; Tomson T; Ulrichsen SP; Zoega H; Furu K
    Ann Neurol; 2023 Mar; 93(3):551-562. PubMed ID: 36433783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
    Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011412. PubMed ID: 28661008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levetiracetam vs Lamotrigine as First-Line Antiseizure Medication in Female Patients With Idiopathic Generalized Epilepsy.
    Cerulli Irelli E; Cocchi E; Morano A; Gesche J; Caraballo RH; Lattanzi S; Strigaro G; Catania C; Ferlazzo E; Pascarella A; Casciato S; Quarato P; Pizzanelli C; Pulitano P; Giuliano L; Viola V; Mostacci B; Fortunato F; Marini C; Di Gennaro G; Gambardella A; Labate A; Operto FF; Giallonardo AT; Baykan B; Beier CP; Di Bonaventura C;
    JAMA Neurol; 2023 Nov; 80(11):1174-1181. PubMed ID: 37782485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Antiseizure Drug Monotherapy and Mortality for Patients With Poststroke Epilepsy.
    Larsson D; Baftiu A; Johannessen Landmark C; von Euler M; Kumlien E; Åsberg S; Zelano J
    JAMA Neurol; 2022 Feb; 79(2):169-175. PubMed ID: 34902006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second antiseizure medication monotherapy in patients with adult-onset epilepsy: A register-based analysis.
    Polychronidis K; Håkansson S; Hosseini Ashtiani S; Idegård A; Larsson D; Zelano J
    Epilepsy Behav; 2024 Jun; 155():109792. PubMed ID: 38669974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends of anti-seizure medication use in pediatric patients in six cities in China from 2013 to 2018.
    Yu L; Feng J; Yu Z; Dai H
    Epilepsy Res; 2020 Nov; 167():106448. PubMed ID: 32916644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in antiseizure medications utilization among women of childbearing age with epilepsy in Poland between 2015 and 2019.
    Wójcik K; Franciszek Kołek M; Dec-Ćwiek M; Słowik A; Bosak M
    Epilepsy Behav; 2023 Feb; 139():109091. PubMed ID: 36682232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection and Continuation of Antiseizure Medication in Children With Epilepsy in Sweden From 2007 to 2020.
    Håkansson S; Wickström R; Zelano J
    Pediatr Neurol; 2023 Jul; 144():19-25. PubMed ID: 37116405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Major Congenital Malformations and Exposure to Antiseizure Medication Monotherapy.
    Battino D; Tomson T; Bonizzoni E; Craig J; Perucca E; Sabers A; Thomas S; Alvestad S; Perucca P; Vajda F;
    JAMA Neurol; 2024 May; 81(5):481-489. PubMed ID: 38497990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Antiseizure Medication Initiation, Switch, or Termination in Patients With Newly Diagnosed Epilepsy: A Nationwide Study.
    Bolin K; Patric B; Tomson T
    Neurology; 2024 Jul; 103(2):e209500. PubMed ID: 38870473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiseizure medication treatment pathways for US Medicare beneficiaries with newly treated epilepsy.
    Terman SW; Youngerman BE; Choi H; Burke JF
    Epilepsia; 2022 Jun; 63(6):1571-1579. PubMed ID: 35294775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal Exposure to Antiseizure Medication and Incidence of Childhood- and Adolescence-Onset Psychiatric Disorders.
    Dreier JW; Bjørk MH; Alvestad S; Gissler M; Igland J; Leinonen MK; Sun Y; Zoega H; Cohen JM; Furu K; Tomson T; Christensen J
    JAMA Neurol; 2023 Jun; 80(6):568-577. PubMed ID: 37067807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam as a first-line antiseizure medication in WHO grade 2 glioma: Time to seizure freedom and rates of treatment failure.
    Fairclough S; Goodden J; Chumas P; Mathew R; Maguire M
    Epilepsia; 2023 Apr; 64(4):857-865. PubMed ID: 36636895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
    Lancet Neurol; 2018 Jun; 17(6):530-538. PubMed ID: 29680205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
    Marson A; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton C; Hughes DA; Williamson P; Baker GA; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE;
    Lancet; 2021 Apr; 397(10282):1363-1374. PubMed ID: 33838757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiseizure medication selection and retention for adult onset focal epilepsy in a Swedish health service region: A population-based cohort study.
    Larsson D; Mroué D; Andrén K; Zelano J
    Epilepsia; 2023 Oct; 64(10):2617-2624. PubMed ID: 37422699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.